hotspot -WSS

hotspot

author：focus 2025-08-04 03:41:57 - browse：53745

A screen at the New York Stock Exchange last November. Michael M. Santiago/Getty Images

Pfizer spent more than four hours Thursday laying out its oncology program to investors. But the company also spent some time talking about the effects of the Inflation Reduction Act on its pipeline.

The drug giant, which is facing investor dissatisfaction after a year in which its stock dropped 44%, said it would be focusing on drugs that are based on proteins, not small molecule pills as it has traditionally developed. (Pfizer’s current best-seller in oncology, Ibrance for breast cancer, is a small molecule pill.) It said the mix of small molecule drugs in its cancer portfolio will drop from 94% last year to 35% in 2030.

That matters because small molecules are more vulnerable to generic competition and the Medicare price negotiation introduced by the IRA. Suneet Varma, the commercial president of Pfizer’s oncology unit, said “this planned shift to biologics is expected to support the accelerated growth in both the top and bottom line,” referring to the revenue and profit lines of a balance sheet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： The response to Covid

WSS

Sophia Smith scores twice for US in in 3

Poland's lawmakers approve a divisive law on Russian influence

Inside the culture of fear in the White House science office of Eric Lander

House GOP plan to stem drug shortages differs from Democrats’

Novartis develops a rapidly manufactured CAR

Drone hits Crimean ammunition depot as strikes kill, wound civilians and journalists in Ukraine

hotspot

hotspot

leisure time

At least 13 dead in Texas as scorching temps continue

Typhoon Doksuri makes landfall in China after bringing deadly landslides to Philippines

BioMarin wins approval for gene therapy to treat hemophilia A

Statins reduce cardiovascular risk in people living with HIV

Duchenne breakthrough therapy leaves behind pioneering families

Novartis develops a rapidly manufactured CAR

Trump demands the U.S. pay no more for drugs than other countries … again

Poland's lawmakers approve a divisive law on Russian influence

BioMarin wins approval for gene therapy to treat hemophilia A

Putin woos African leaders at a summit in Russia with promises of expanding trade and other ties

focus

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

Woman found dead after suspected bear encounter near Yellowstone, wildlife officials say

Sophia Smith scores twice for US in in 3

Typhoon Doksuri makes landfall in China after bringing deadly landslides to Philippines

Europe is fastest

5 wounded, 2 critically, in Michigan shopping center shooting

knowledge

explore

explore

focus